BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8958387)

  • 1. A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin ELISA test.
    Elalamy I; Potevin F; Lecrubier C; Bara L; Marie JP; Samama MM
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):665-71. PubMed ID: 8958387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
    Ahmad S; Haas S; Hoppensteadt DA; Lietz H; Reid U; Bender N; Messmore HL; Misselwitz F; Bacher P; Gaikwad BS; Jeske WP; Walenga JM; Fareed J
    Thromb Res; 2002 Oct; 108(1):49-55. PubMed ID: 12586132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.
    Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y
    Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay.
    Greinacher A; Amiral J; Dummel V; Vissac A; Kiefel V; Mueller-Eckhardt C
    Transfusion; 1994 May; 34(5):381-5. PubMed ID: 8191560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
    N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.
    Alexy T; Tucker S; Boyle S; Rowe VL; Weaver FA; Liebman HA
    J Vasc Surg; 2008 Aug; 48(2):377-81. PubMed ID: 18515040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.
    Greinacher A; Pötzsch B; Amiral J; Dummel V; Eichner A; Mueller-Eckhardt C
    Thromb Haemost; 1994 Feb; 71(2):247-51. PubMed ID: 8191407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
    Pouplard C; Amiral J; Borg JY; Vissac AM; Delahousse B; Gruel Y
    Br J Haematol; 1997 Nov; 99(2):273-80. PubMed ID: 9375738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a whole-cell ELISA to detect additional antibodies in setting of suspected heparin-induced thrombocytopenia.
    Bashover EM; Stefaniuk CM; Harding CV; Maitta RW
    Eur J Haematol; 2019 Aug; 103(2):99-106. PubMed ID: 31107976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
    Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
    Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
    Look KA; Sahud M; Flaherty S; Zehnder JL
    Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
    Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
    Blank M; Cines DB; Arepally G; Eldor A; Afek A; Shoenfeld Y
    Clin Exp Immunol; 1997 May; 108(2):333-9. PubMed ID: 9158107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
    Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
    Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies to the heparin/platelet factor 4 complex are an independent predictor of thrombotic complications following pediatric fontan surgery.
    Zhang R; Huang Y; Zhang M; Bai J; Liu J
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):448-52. PubMed ID: 22679243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.